Phenylketonuria—Past, Present, and Future Directions
OBM Genetics · 16.08.2024 · 08 (03) · 1-21
DOI: 10.21926/obm.genet.2403256 ↗Kurz gefasst
Fachartikel in der Zeitschrift OBM Genetics, online erschienen am 16.08.2024. Verfasst von Nicole A. Bailey und 1 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Phenylketonuria (PKU) is an autosomal recessive inborn error of metabolism with an incidence that varies throughout the world. PKU is caused by loss of function variants in the phenylalanine hydroxylase gene. This loss of function leads to the accumulation of an amino acid, phenylalanine (Phe), that can reach toxic levels in the blood. PKU is managed with a medical diet and sometimes with medication. If diagnosed early and with strict dietary control, neurocognitive deficits can be prevented. There is an important need to ensure the timely diagnosis of PKU and to develop newer therapies to treat this metabolic disorder.
Zitieren
APA
Bailey, N. A., & Mackay, L. (2024). Phenylketonuria—Past, Present, and Future Directions. OBM Genetics, 08(03), 1-21. https://doi.org/10.21926/obm.genet.2403256
Vancouver
Bailey NA, Mackay L. Phenylketonuria—Past, Present, and Future Directions. OBM Genetics. 2024;08(03):1-21. doi:10.21926/obm.genet.2403256
BibTeX
@article{Bailey2024,
author = {Bailey, Nicole A. and Mackay, Laura},
title = {Phenylketonuria—Past, Present, and Future Directions},
journal = {OBM Genetics},
year = {2024},
volume = {08},
number = {03},
pages = {1--21},
doi = {10.21926/obm.genet.2403256}
}
EUVIMED